Abstract:The structural transition of prion proteins from a native alpha-helix (PrPC) to a misfolded beta-sheet-rich conformation (PrPSc) is believed to be the main cause of a number of prion diseases in humans and animals. Understanding the molecular basis of misfolding and aggregation of prion proteins will be valuable for unveiling the etiology of prion diseases. However, due to the limitation of conventional experimental techniques and the heterogeneous property of oligomers, little is known about the molecular architecture of misfolded PrPSc and the mechanism of structural transition from PrPC to PrPSc. The prion fragment 127-147 (PrP127-147) has been reported to be a critical region for PrPSc formation in Gerstmann-Straussler-Scheinker (GSS) syndrome and thus has been used as a model for the study of prion aggregation. In the present study, we employ molecular dynamics (MD) simulation techniques to study the conformational change of this fragment that could be relevant to the PrPC-PrPSc transition. Employing extensive replica exchange molecular dynamics (REMD) and conventional MD simulations, we sample a huge number of conformations of PrP127-147. Using the Markov state model (MSM), we identify the metastable conformational states of this fragment and the kinetic network of transitions between the states. The resulting MSM reveals that disordered random-coiled conformations are the dominant structures. A key metastable folded state with typical extended beta-sheet structures is identified with Pro137 being located in a turn region, consistent with a previous experimental report. Conformational analysis reveals that intrapeptide hydrophobic interaction and two key residue interactions, including Arg136-His140 and Pro137-His140, contribute a lot to the formation of ordered extended beta-sheet states. However, network pathway analysis from the most populated disordered state indicates that the formation of extended beta-sheet states is quite slow (at the millisecond level), as large structural rearrangement is needed from disordered states. We speculate that the formation process of the extended beta-sheet folded states may represent an important event during the early formation of prion oligomers and the results of our study provide insights into the molecular details of the early stage of prion aggregation.

Effects of the A117v Mutation on the Folding and Aggregation of Palindromic Sequences (Prp113-120) in Prion: Insights from Replica Exchange Molecular Dynamics Simulations

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Biophysical Characterization of Oligomerization and Fibrillization of the G131V Pathogenic Mutant of Human Prion Protein.

Distinct Effects of Mutations on Biophysical Properties of Human Prion Protein Monomers and Oligomers.

Influence of the Pathogenic Mutations T188k/R/A on the Structural Stability and Misfolding of Human Prion Protein: Insight from Molecular Dynamics Simulations

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

N-terminal Prion Protein Peptides (prp(120–144)) Form Parallel In-Register Β-Sheets Via Multiple Nucleation-Dependent Pathways.

Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations.

The Folding Mechanism And Key Metastable State Identification Of The Prp127-147 Monomer Studied By Molecular Dynamics Simulations And Markov State Model Analysis

Effect Of Amino Acid Sequence Rearrangment On Prion Aggregation: Molecular Dynamics Simulations Of An Amyloid-Forming Peptide From The Yeast Prion Sup35p

Exploring structural and thermodynamic stabilities of human prion protein pathogenic mutants D202N, E211Q and Q217R.

Interaction Between 14-3-3β and PrP Influences the Dimerization of 14-3-3 and Fibrillization of PrP106-126.

PrP Mutants with Different Numbers of Octarepeat Sequences Are More Susceptible to the Oxidative Stress

Structural and Dynamical Mechanisms of a Naturally Occurring Variant of the Human Prion Protein in Preventing Prion Conversion?

Aggregation of Prion Protein with Insertion Mutations is Proportional to the Number of Inserts

Experimental and Theoretical Insights into the Inhibition Mechanism of Prion Fibrillation by Resveratrol and Its Derivatives

Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease.

Manganese-induced Changes of the Biochemical Characteristics of the Recombinant Wild-Type and Mutant PrPs

Solution Structure and Dynamics of the I214V Mutant of the Rabbit Prion Protein.

Dissecting How ALS-associated D290V Mutation Enhances Pathogenic Aggregation of Hnrnpa2286–291 Peptides: Dynamics and Conformational Ensembles

In Situ Molecular-Level Insights into the Interfacial Structure Changes of Membrane-Associated Prion Protein Fragment [118-135] Investigated by Sum Frequency Generation Vibrational Spectroscopy.